Antisense And Nucleic Acid Drug Development impact factor, indexing, ranking (2024)


antisense

Aim and Scope

The Antisense And Nucleic Acid Drug Development is a research journal published by the Mary Ann Liebert Inc.. The P-ISSN of this journal is 10872906.

Also, please check the following important details about antisense and nucleic acid drug development: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.


Important Metrics

Journal Title: Antisense and Nucleic Acid Drug Development
Publisher: Mary Ann Liebert Inc.
P-ISSN: 10872906
Open Access:
Status: Inactive
Scopus Coverage: 1996-2003

antisense and nucleic acid drug development Indexing

The antisense and nucleic acid drug development is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Antisense And Nucleic Acid Drug Development?

If your research is related to the scope of the journal, then visit the official website of antisense and nucleic acid drug development and send your manuscript.

Tips for publishing in Antisense And Nucleic Acid Drug Development:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.


Final Summary

  • It is published by Mary Ann Liebert Inc..
  • The journal is indexed in NA.

Sources: antisense and nucleic acid drug development







TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.